الصفحة الرئيسية>>Signaling Pathways>> Metabolism>> Bile Acids & Microbiome>>Ursodeoxycholic Acid (sodium salt)

Ursodeoxycholic Acid (sodium salt) (Synonyms: UDCA, Ursodiol)

رقم الكتالوجGC45132

حمض Ursodeoxycholic (Ursodeoxycholate) الصوديوم هو حمض صفراوي ثانوي ناتج عن تحول حمض (cheno) deoxycholic بواسطة البكتيريا المعوية ، ويعمل كمنظم رئيسي لسلامة الحاجز المعوي وضروري لاستقلاب الدهون.

Products are for research use only. Not for human use. We do not sell to patients.

Ursodeoxycholic Acid (sodium salt) التركيب الكيميائي

Cas No.: 2898-95-5

الحجم السعر المخزون الكميّة
250mg
56٫00
متوفر
500mg
90٫00
متوفر
1g
162٫00
متوفر
5g
567٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Ursodeoxycholic acid (UDCA) is a secondary bile acid formed via epimerization of chenodeoxycholic acid . UDCA is also a metabolite of lithocholic acid in human liver microsomes. It inhibits taurocholic acid uptake in HeLa cells expressing recombinant sodium/taurocholate cotransporting polypeptide (NTCP) with an IC50 value of 3.6 μM. UDCA (50 μM) inhibits apoptosis induced by deoxycholic acid or ethanol in primary rat hepatocytes. Dietary administration of UDCA blocks DCA-induced increases in the number of TUNEL-positive hepatocytes in rats. Formulations containing UDCA have been used in the treatment of primary biliary cirrhosis.

مراجعات

Review for Ursodeoxycholic Acid (sodium salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 5 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Ursodeoxycholic Acid (sodium salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.